Korean Stock
MATR
Dongsung Pharmaceutical
★
Dongsung Pharmaceutical Decides to Cancel 250,000 Common Shares Under Rehabilitation Plan
 05/13/2026, 03:07 PM
EXCH
Dongsung Pharmaceutical
★
Decision to Appoint Audit Committee Members During Rehabilitation
 05/11/2026, 02:19 PM
PERI
Dongsung Pharmaceutical
★★★
Dongsung Pharm: 2025 operating loss of 10.1B KRW, rehabilitation plan approved with major shareholder change
 05/06/2026, 04:20 PM
PERI
Dongsung Pharmaceutical
★★★
Dongsung Pharm: Operating Loss, Qualified Opinion, Deteriorating Financial Health
 05/06/2026, 04:16 PM
PERI
Dongsung Pharmaceutical
★★★★
Dongsung Pharmaceutical Audit Report Corrected: Opinion Downgraded to Qualified, Internal Control Disclaimer
 05/06/2026, 04:12 PM
EXCH
Dongsung Pharmaceutical
★★★★
Dong Sung Pharmaceutical Files to Terminate Rehabilitation: Normalization After 160 Billion Won Investment
 05/06/2026, 03:43 PM
EXCH
Dongsung Pharmaceutical
★★★
Audit Report Correction: Prior Year Opinion Revised to Qualified, Internal Control Adverse
 05/03/2026, 07:00 AM
EXCH
Dongsung Pharmaceutical
★★★
Audit Report Correction: Qualified Opinion, Adverse Internal Control, Fraud Disclosure
 05/03/2026, 07:00 AM